Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.8
(-1.01%)
CNY 12.8
(-1.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -499.02 Million CNY | 65.56% |
| 2022 | -1.44 Billion CNY | -235.03% |
| 2021 | 1.07 Billion CNY | 209.42% |
| 2020 | -980.85 Million CNY | -243.2% |
| 2019 | 684.95 Million CNY | 60.89% |
| 2018 | 425.73 Million CNY | 152.39% |
| 2017 | -812.56 Million CNY | -38.01% |
| 2016 | -588.79 Million CNY | -8.24% |
| 2015 | -543.96 Million CNY | 24.49% |
| 2014 | -720.4 Million CNY | -16.25% |
| 2013 | -619.7 Million CNY | -25.82% |
| 2012 | -492.54 Million CNY | 13.89% |
| 2011 | -572 Million CNY | 19.45% |
| 2010 | -710.14 Million CNY | 17.2% |
| 2009 | -857.71 Million CNY | -2485.27% |
| 2008 | 35.95 Million CNY | 46.1% |
| 2007 | 24.61 Million CNY | -2.24% |
| 2006 | 25.17 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.03 Billion CNY | -106.68% |
| 2024 Q2 | 1.33 Billion CNY | 229.42% |
| 2024 Q3 | -4.09 Billion CNY | -68.27% |
| 2023 Q1 | -1.68 Billion CNY | -16.05% |
| 2023 Q3 | -2.21 Billion CNY | -27.68% |
| 2023 Q4 | -499.02 Million CNY | 77.49% |
| 2023 FY | -499.02 Million CNY | 65.56% |
| 2023 Q2 | -1.73 Billion CNY | -3.25% |
| 2022 Q2 | 655.03 Million CNY | -47.45% |
| 2022 Q3 | -3.38 Billion CNY | -616.9% |
| 2022 Q1 | 1.24 Billion CNY | 16.13% |
| 2022 FY | -1.44 Billion CNY | -235.03% |
| 2022 Q4 | -1.44 Billion CNY | 57.2% |
| 2021 FY | 1.07 Billion CNY | 209.42% |
| 2021 Q2 | 1.31 Billion CNY | -24.69% |
| 2021 Q4 | 1.07 Billion CNY | 66.5% |
| 2021 Q3 | 644.58 Million CNY | -50.8% |
| 2021 Q1 | 1.73 Billion CNY | 277.34% |
| 2020 FY | -980.85 Million CNY | -243.2% |
| 2020 Q4 | -980.85 Million CNY | 12.44% |
| 2020 Q3 | -1.12 Billion CNY | -453.19% |
| 2020 Q2 | 317.17 Million CNY | -46.87% |
| 2020 Q1 | 597.03 Million CNY | -12.84% |
| 2019 FY | 684.95 Million CNY | 60.89% |
| 2019 Q1 | 451.77 Million CNY | 6.11% |
| 2019 Q2 | 792.32 Million CNY | 75.38% |
| 2019 Q3 | 218.71 Million CNY | -72.4% |
| 2019 Q4 | 684.95 Million CNY | 213.17% |
| 2018 Q2 | 396.21 Million CNY | 165.16% |
| 2018 Q4 | 425.73 Million CNY | 59.19% |
| 2018 FY | 425.73 Million CNY | 152.39% |
| 2018 Q1 | -608.06 Million CNY | 25.17% |
| 2018 Q3 | 267.44 Million CNY | -32.5% |
| 2017 Q1 | -444.64 Million CNY | 24.48% |
| 2017 FY | -812.56 Million CNY | -38.01% |
| 2017 Q4 | -812.56 Million CNY | -194.83% |
| 2017 Q3 | 856.88 Million CNY | 566.48% |
| 2017 Q2 | -183.69 Million CNY | 58.69% |
| 2016 FY | -588.79 Million CNY | -8.24% |
| 2016 Q3 | -397.35 Million CNY | 36.54% |
| 2016 Q2 | -626.15 Million CNY | -70.39% |
| 2016 Q1 | -367.48 Million CNY | 32.44% |
| 2016 Q4 | -588.79 Million CNY | -48.18% |
| 2015 Q1 | -594.07 Million CNY | 17.54% |
| 2015 FY | -543.96 Million CNY | 24.49% |
| 2015 Q4 | -543.96 Million CNY | 21.98% |
| 2015 Q3 | -697.25 Million CNY | -20.48% |
| 2015 Q2 | -578.73 Million CNY | 2.58% |
| 2014 Q3 | -629.5 Million CNY | -19.79% |
| 2014 Q1 | -571.95 Million CNY | 7.71% |
| 2014 Q2 | -525.51 Million CNY | 8.12% |
| 2014 FY | -720.4 Million CNY | -16.25% |
| 2014 Q4 | -720.4 Million CNY | -14.44% |
| 2013 FY | -619.7 Million CNY | -25.82% |
| 2013 Q4 | -619.7 Million CNY | -3.49% |
| 2013 Q3 | -598.83 Million CNY | -22.99% |
| 2013 Q2 | -486.87 Million CNY | 12.94% |
| 2013 Q1 | -559.25 Million CNY | -13.54% |
| 2012 Q4 | -492.54 Million CNY | -3.46% |
| 2012 Q1 | -473.8 Million CNY | 17.17% |
| 2012 FY | -492.54 Million CNY | 13.89% |
| 2012 Q2 | -396.32 Million CNY | 16.35% |
| 2012 Q3 | -476.07 Million CNY | -20.12% |
| 2011 FY | -572 Million CNY | 19.45% |
| 2011 Q4 | -572 Million CNY | 4.36% |
| 2011 Q2 | -559.93 Million CNY | 17.04% |
| 2011 Q1 | -674.95 Million CNY | 4.96% |
| 2011 Q3 | -598.07 Million CNY | -6.81% |
| 2010 Q2 | -744.23 Million CNY | 14.18% |
| 2010 Q4 | -710.14 Million CNY | 9.32% |
| 2010 FY | -710.14 Million CNY | 17.2% |
| 2010 Q1 | -867.24 Million CNY | -1.11% |
| 2010 Q3 | -783.1 Million CNY | -5.22% |
| 2009 FY | -857.71 Million CNY | -2485.27% |
| 2009 Q4 | -857.71 Million CNY | -16058.16% |
| 2009 Q2 | 17.05 Million CNY | 0.0% |
| 2009 Q3 | -5.3 Million CNY | -131.13% |
| 2008 Q4 | 35.95 Million CNY | 0.0% |
| 2008 FY | 35.95 Million CNY | 46.1% |
| 2007 FY | 24.61 Million CNY | -2.24% |
| 2006 FY | 25.17 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 11.05 Billion CNY | 104.513% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 3.48 Billion CNY | 114.308% |